Efficacy and safety of trimodulin in patients with severe COVID-19: results from a randomised, placebo-controlled, double-blind, multicentre, phase II trial (ESsCOVID) by Alina Agafina, Valeria Cristina Aguiar, Maria Rossovskaya, Muriel Sarah Fartoukh, Ludhmila Abrahao Hajjar, Guillaume Thiéry, Jean-François Timsit, Ivan Gordeev, Denis Protsenko, Javier Carbone, Rita Pellegrini, Claudio Marcel Berdun Stadnik, Sergey Avdeev, Miquel Ferrer, Corina C Heinz, Thomas Häder, Patrick Langohr, Iris Bobenhausen, Jörg Schüttrumpf, Alexander Staus, Markus Ruehle, Sabrina Weissmüller, Andrea Wartenburg-Demand, Antoni Torres

Get full text